帕金森病中的冲动性特征:系统审查和元分析
Fabio Giovannelli1, Gioele Gavazzi1, Chiara Noferini1,2
1Department of Neuroscience, Psychology, Drug Research and Child's Health (NEUROFARBA), Section of Psychology University of Florence Florence Italy.
Movement disorders clinical practice
|October 23, 2023
概括
与健康个体相比,帕金森病患者的特征冲动性更高. 这种冲动性在治疗期间发展出冲动控制障碍 (ICD) 的PD患者中更加明显.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 运动障碍 运动障碍
背景情况:
- 冲动性作为一种人格特质是帕金森病 (PD) 患者进行多巴胺疗法的冲动控制障碍 (ICD) 的潜在危险因素.
- 关于PD患者与对照患者的特征冲动性差异,以及具有与没有ICD的PD患者的特征冲动性差异的先前研究已经产生了不一致的结果.
研究的目的:
- 在帕金森病 (PD) 患者中,系统地审查和元分析比较特征冲动性的研究,用巴拉特冲动性量表 (BIS-11) 测量.
- 为了比较PD患者和健康对照者之间的BIS-11分数.
- 为了比较PD患者与没有冲动控制障碍 (ICD) 之间的BIS-11分数.
主要方法:
- 在三个数据库中进行了系统的搜索,以确定符合条件的研究.
- 进行了元分析,以计算BIS-11总和分量级分数的平均差异和95%置信区间.
- 使用元回归来调查异质性的潜在来源,包括患者人口统计和药物剂量.
主要成果:
- 分析包括了40项研究.
- 与健康对照组相比,帕金森病 (PD) 患者的BIS-11总分数显著更高 (平均差异2.43;95% CI,1.03,3.83).
- 患有活跃冲动控制障碍 (ICD) 的PD患者的BIS-11总得分明显高于没有ICD的患者 (平均差异6.62;95%CI,5.01,8.23).
结论:
- 提升的特征冲动性是帕金森病 (PD) 患者的特征,无论冲动控制障碍 (ICD) 状态如何.
- 这些发现加强了现有的临床观察,在患有ICD的PD患者中增加了特征冲动性.
更多相关视频
相关概念视频
Parkinson's Disease: Treatment
281
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
281
Parkinson's Disease: Overview
567
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
567
Attention-Deficit/Hyperactivity Disorder
73
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
73


